Over the last 7 days, the United States market has dropped by 1.0%, but it remains up 23% over the past year, with earnings forecasted to grow by 17% annually. In such a dynamic landscape, identifying stocks that combine value and growth potential is key, especially when considering smaller or younger companies often referred to as penny stocks. Though the term may seem outdated, these investments can still offer significant opportunities for those looking to discover under-the-radar companies with strong financial foundations and promising growth prospects.

Let's review some notable picks from our screened stocks.

Cerus (CERS)

Simply Wall St Financial Health Rating: ★★★★★☆

Overview: Cerus Corporation is a biomedical products company with a market cap of $486.90 million.

Operations: The company generates revenue primarily from its Blood Safety segment, amounting to $216.56 million.

Market Cap: $486.9M

Cerus Corporation, with a market cap of US$486.90 million, is navigating the penny stock landscape with a focus on growth despite current unprofitability. Its revenue from the Blood Safety segment reached US$216.56 million, and recent guidance suggests an increase to US$227-231 million for 2026. The company's short-term assets exceed its liabilities, indicating financial stability, while its net debt to equity ratio remains satisfactory at 6.5%. Recent developments include a new supply agreement in France and leadership changes aimed at sustaining growth momentum as earnings are forecasted to grow significantly in the coming years.

Alight (ALIT)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: Alight, Inc. is a technology-enabled services company operating globally with a market cap of approximately $423.03 million.

Operations: The Employer Solutions segment generated $2.25 billion in revenue.

Market Cap: $423.03M

Alight, Inc., with a market cap of US$423.03 million, is navigating challenges in the penny stock domain while leveraging its Employer Solutions segment, which generated US$2.25 billion in revenue. Despite being unprofitable and facing a high net debt to equity ratio of 176.7%, Alight maintains a positive cash flow runway exceeding three years. Recent strategic moves include expanding its Alight Partner Network with Cylinder Health and Leap to enhance health solutions for employers, though it also faces compliance issues with NYSE listing standards due to low share prices and ongoing legal disputes over investor communications.

High Templar Tech (HTT)

Simply Wall St Financial Health Rating: ★★★★☆☆

Overview: High Templar Tech Limited is a consumer-oriented financial technology service company operating in the People’s Republic of China with a market cap of $338.52 million.

Operations: The company generates CN¥40.96 million from its Installment Credit Services segment.

Market Cap: $338.52M

High Templar Tech Limited, with a market cap of $338.52 million, has faced significant revenue challenges, reporting CN¥40.96 million for the full year 2025 compared to CN¥216.43 million the previous year. Despite this decline, the company completed a substantial share buyback program and maintains strong financial health with short-term assets significantly exceeding liabilities and more cash than total debt. Its earnings growth over the past year was very large at 672.5%, outpacing industry averages, though its price-to-earnings ratio remains low at 3.3x compared to the US market average of 18.5x, indicating potential undervaluation in its sector.

Turning Ideas Into Actions

• Unlock our comprehensive list of 356 US Penny Stocks by clicking here.
• Ready For A Different Approach? Find companies with promising cash flow potential yet trading below their fair value.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.